Product Name | BSI 201 |
Description |
PARP1 inhibitor |
Purity | >98% |
CAS No. | 160003-66-7 |
Molecular Formula | C7H5IN2O3 |
Molecular Weight | 292 |
Field of Use | Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only. |
Storage Temperature | -20ºC |
Shipping Temperature | Shipped Ambient |
Product Type | Inhibitor |
Solubility | Soluble in DMSO (5 mg/ml) |
Source | Synthetic |
Appearance | White to beige powder |
SMILES | C1=CC(=C(C=C1C(=O)N)[N+](=O)[O-])I |
InChI | 1S/C7H5IN2O3/c8-5-2-1-4(7(9)11)3-6(5)10(12)13/h1-3H,(H2,9,11) |
InChIKey | MDOJTZQKHMAPBK-UHFFFAOYSA-N |
Safety Phrases |
Classification: D2B Toxic Material Causing Other Toxic Effects - Moderate eye irritant Hazard statement(s): H302 Harmful if swallowed. H319 Causes serious eye irritation. Precautionary statement(s): P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
Cite This Product | BSI 201 (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-539) |
Alternative Names | Iniparib, 4-Iodo-3-nitrobenzamide, BSI-201, 4-iodo-3-nitro-benzamide, Iniparib (BSI-201) |
Research Areas | Cancer, Cancer Growth Inhibitors |
PubChem ID | 9796068 |
Scientific Background | BSI 201 is a small molecule PARP1 inhibitor. It is cytotoxic in cells with DNA alterations or DNA damage, thereby inhibiting the growth of tumor cells. |
Reviews
There are no reviews yet.